- Home
- XRTX vs CHR Comparison
XRTX vs CHR Comparison
Compare XRTX & CHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XRTX | CHR |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 3.8M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | XRTX | CHR |
|---|---|---|
| Price | $2.19 | $1.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.3K | ★ 51.4K |
| Earning Date | 05-15-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.35 | $0.03 |
| 52 Week High | $3.60 | $2.95 |
Technical Indicators
Market Signals| Indicator | XRTX | CHR |
|---|---|---|
| Relative Strength Index (RSI) | 57.19 | 49.13 |
| Support Level | $2.00 | $1.70 |
| Resistance Level | $2.24 | $2.00 |
| Average True Range (ATR) | 0.11 | 0.16 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 81.25 | 24.47 |
Price Performance
Historical ComparisonAbout XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.